Alaunos Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-MSD Partners, L.P.(6.3%),MSD Credit Opportunity Master Fund, L.P.(6.3%)等
Alaunos Therapeutics | 4:持股變動聲明-高管 Groenewald Ferdinand
Alaunos Therapeutics | 4:持股變動聲明-高管 Lackey Melinda
Alaunos Therapeutics | 4:持股變動聲明-董事 Hofmeister Robert
Alaunos Therapeutics | 4:持股變動聲明-董事 Weis Holger
Alaunos Therapeutics | 4:持股變動聲明-董事 Vieser Jaime
Alaunos Therapeutics | 4:持股變動聲明-董事 Postma Robert W
Alaunos Therapeutics | 3:首次持股聲明-高管 Groenewald Ferdinand
Alaunos Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Discovery Capital Management, LLC(1.66%),Robert K. Citrone(1.66%)等
Alaunos Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-MSD Partners, L.P.(9.2%),MSD Credit Opportunity Master Fund, L.P.(9.2%)等
Alaunos Therapeutics | 4:持股變動聲明-高管 Hogue Dale Curtis Jr.
Alaunos Therapeutics | 4:持股變動聲明-董事 Hogue Dale Curtis Jr.
Alaunos Therapeutics | 3:首次持股聲明-董事 Hogue Dale Curtis Jr.
Alaunos Therapeutics | 4:持股變動聲明-首席執行官 Boyle Kevin S. Sr.
Alaunos Therapeutics | 4:持股變動聲明-董事 Postma Robert W
Alaunos Therapeutics | 4:持股變動聲明-董事 Hofmeister Robert
Alaunos Therapeutics | 4:持股變動聲明-董事 Thistle Mary
Alaunos Therapeutics | 4:持股變動聲明-董事 Huang James
Alaunos Therapeutics | 4:持股變動聲明-董事 Vieser Jaime
Alaunos Therapeutics | 4:持股變動聲明-董事 Weis Holger
暫無數據
暫無數據